688602.SHG CHEMSPEC ORD A (SHH) EQSW Exp:
- Market cap
- CNY 3.29B
- P/E
- -
- P/B
- 1.17x
- ROE
- -3.0%
- Dividend yield
- 0.15%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 688602.SHG undervalued?
Graham numberThe Graham number of CHEMSPEC ORD A (SHH) EQSW Exp: cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CHEMSPEC ORD A (SHH) EQSW Exp: fundamental analysis
No fundamental analysis for CHEMSPEC ORD A (SHH) EQSW Exp: yet.
CHEMSPEC ORD A (SHH) EQSW Exp: stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CHEMSPEC ORD A (SHH) EQSW Exp:
Shanghai Chemspec Corporation, together with its subsidiaries, engages in the research, development, production, and sale of fine chemicals in China and internationally. The company offers display materials, including fluorinated liquid crystal monomers and intermediates; new energy battery materials and electronic chemicals, such as lithium bisfluorosulfonyl imide (LiFSI); and organosilicon materials, including silicone pressure-sensitive adhesives and phenylacetylene. It a…
Full company profileCHEMSPEC ORD A (SHH) EQSW Exp: financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CHEMSPEC ORD A (SHH) EQSW Exp: annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.00B | 1.24B | 980M | 675M | 770M | 622M |
| Gross Profit | 347M | 364M | 277M | 85.4M | 123M | 43.8M |
| Operating Income | 190M | 184M | 101M | -94.5M | -34.7M | -120M |
| EBITDA | - | 337M | 271M | 101M | 93.9M | -93.1M |
| Net Income | 134M | 181M | 113M | -49.5M | -64.2M | -81.6M |
| EPS | 0.32 | 0.43 | 0.22 | -0.10 | -0.12 | -0.16 |
| Balance Sheet | ||||||
| Total Assets | 2.39B | 2.54B | 3.30B | 3.26B | 3.15B | 3.06B |
| Total Liabilities | 759M | 692M | 512M | 471M | 427M | 359M |
| Shareholders' Equity | 1.62B | 1.83B | 2.77B | 2.77B | 2.72B | 2.69B |
| Cash & Short-term Investments | 411M | 389M | 1.30B | 1.18B | 1.20B | 735M |
| Cash Flow | ||||||
| Operating Cash Flow | 101M | 159M | 213M | 60.8M | 136M | - |
| Capital Expenditure | 177M | 146M | 131M | 162M | 124M | 72.5M |
| Free Cash Flow | -76.1M | 13.2M | 81.4M | -101M | 12.3M | -120M |
| Ratios | ||||||
| ROE | 8.3% | 9.8% | 4.1% | -1.8% | -2.4% | -3.0% |
| ROA | 5.6% | 7.1% | 3.4% | -1.5% | -2.0% | -2.7% |
| Net Profit Margin | 13.3% | 14.6% | 11.5% | -7.3% | -8.3% | -13.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CHEMSPEC ORD A (SHH) EQSW Exp: dividends
- Dividend yield
- 0.15%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 25, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 4.96M | 0.01 | - |
| 2024 | CNY 40.5M | 0.08 | - |
| 2023 | CNY 8.07M | 0.02 | 7.2% |
| 2022 | CNY 8.82M | 0.02 | 4.9% |
| 2021 | CNY 12.2M | 0.03 | 9.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns CHEMSPEC ORD A (SHH) EQSW Exp:
- Insiders 54.51%
- Institutions 7.25%
- Public & others 38.24%
- Shares outstanding 519M
- Free float 273M
CHEMSPEC ORD A (SHH) EQSW Exp: company profile
- Company name
- CHEMSPEC ORD A (SHH) EQSW Exp:
- Ticker
- 688602.SHG
- Exchange
- Shanghai Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 992
- Fiscal year end
- December
- Address
- Building 1, No. 200, Lane 2891, Shanghai, China, 200331
- Phone
- 86 21 6363 9090
- Website
- chemspec.com.cn
About CHEMSPEC ORD A (SHH) EQSW Exp:
Shanghai Chemspec Corporation, together with its subsidiaries, engages in the research, development, production, and sale of fine chemicals in China and internationally. The company offers display materials, including fluorinated liquid crystal monomers and intermediates; new energy battery materials and electronic chemicals, such as lithium bisfluorosulfonyl imide (LiFSI); and organosilicon materials, including silicone pressure-sensitive adhesives and phenylacetylene. It also provides pharmaceutical chemicals, such as active pharmaceutical ingredients and intermediates; and pesticide chemicals, including active ingredients and intermediates for insecticides, fungicides, and acaricides. In addition, the company offers contract development and manufacturing organization (CDMO) services. It exports its products primarily to Japan. Shanghai Chemspec Corporation was founded in 1996 and is headquartered in Shanghai, China.
CHEMSPEC ORD A (SHH) EQSW Exp: management
10- Dr. Jianhua Yang Ph.D.Founder & Chairman of the Board · born 1955
- Mr. Yunlong YuanGM & Director · born 1974
- Ms. Xi PingDeputy GM, Financial Director & Director · born 1972
- Mr. Peng GuangrongDeputy GM and Director of Production & Operation Center · born 1976
- Mr. He LiDeputy GM & Head of Technology Research and Development · born 1976
- Mr. Chongbo YangDeputy GM & Director · born 1987
- Ms. Xi ZhangSecretary to the Board · born 1993
- Mr. Yong Tao CuiDeputy General Manager · born 1982
- Mr. Wei CuiAccounting Supervisor
- Mr. Weiquan SunDeputy General Manager · born 1971